BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23328523)

  • 1. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.
    Willner DL; Hugenholtz P; Yerkovich ST; Tan ME; Daly JN; Lachner N; Hopkins PM; Chambers DC
    Am J Respir Crit Care Med; 2013 Mar; 187(6):640-7. PubMed ID: 23328523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.
    Botha P; Archer L; Anderson RL; Lordan J; Dark JH; Corris PA; Gould K; Fisher AJ
    Transplantation; 2008 Mar; 85(5):771-4. PubMed ID: 18337673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
    Vos R; Vanaudenaerde BM; Geudens N; Dupont LJ; Van Raemdonck DE; Verleden GM
    Eur Respir J; 2008 May; 31(5):1037-45. PubMed ID: 18256072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.
    Charlson ES; Diamond JM; Bittinger K; Fitzgerald AS; Yadav A; Haas AR; Bushman FD; Collman RG
    Am J Respir Crit Care Med; 2012 Sep; 186(6):536-45. PubMed ID: 22798321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
    Wolf T; Oumeraci T; Gottlieb J; Pich A; Brors B; Eils R; Haverich A; Schlegelberger B; Welte T; Zapatka M; von Neuhoff N
    Transplantation; 2011 Aug; 92(4):477-85. PubMed ID: 21716170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
    Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients.
    Dhillon GS; Valentine VG; Levitt J; Patel P; Gupta MR; Duncan SR; Seoane L; Weill D
    Clin Transplant; 2012; 26(1):105-10. PubMed ID: 21352378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients.
    Vital D; Hofer M; Benden C; Holzmann D; Boehler A
    Respiration; 2013; 86(1):25-31. PubMed ID: 22922656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiolitis obliterans syndrome susceptibility and the pulmonary microbiome.
    Schott C; Weigt SS; Turturice BA; Metwally A; Belperio J; Finn PW; Perkins DL
    J Heart Lung Transplant; 2018 Sep; 37(9):1131-1140. PubMed ID: 29929823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; ViganĂ² M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation.
    Reid DW; Walters EH; Johns DP; Ward C; Burns GP; Liakakos P; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Apr; 24(4):489-92. PubMed ID: 15797754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.
    Weigt SS; Elashoff RM; Huang C; Ardehali A; Gregson AL; Kubak B; Fishbein MC; Saggar R; Keane MP; Saggar R; Lynch JP; Zisman DA; Ross DJ; Belperio JA
    Am J Transplant; 2009 Aug; 9(8):1903-11. PubMed ID: 19459819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.